• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microorganisms . Multiple Secondary Healthcare-Associated Infections Due to Carbapenem-Resistant Organisms in a Critically Ill COVID-19 Patient on E

tetano

Editor, Senior Moderator
Microorganisms


. 2021 Dec 23;10(1):19.
doi: 10.3390/microorganisms10010019.
Multiple Secondary Healthcare-Associated Infections Due to Carbapenem-Resistant Organisms in a Critically Ill COVID-19 Patient on Extensively Prolonged Venovenous Extracorporeal Membrane Oxygenation Support-A Case Report


Hiroaki Baba[SUP] 1 2 [/SUP], Hajime Kanamori[SUP] 1 2 3 [/SUP], Issei Seike[SUP] 1 [/SUP], Ikumi Niitsuma-Sugaya[SUP] 1 [/SUP], Kentaro Takei[SUP] 1 [/SUP], Kengo Oshima[SUP] 1 2 [/SUP], Yudai Iwasaki[SUP] 4 [/SUP], Yuko Ogata[SUP] 4 [/SUP], Hirona Nishimaki[SUP] 4 [/SUP], Daisuke Konno[SUP] 4 [/SUP], Takuya Shiga[SUP] 4 [/SUP], Koji Saito[SUP] 4 [/SUP], Koichi Tokuda[SUP] 1 2 3 [/SUP], Tetsuji Aoyagi[SUP] 1 2 [/SUP]



Affiliations

Abstract

Patients with severe Coronavirus disease 2019 (COVID-19) are at high risk for secondary infection with multidrug-resistant organisms (MDROs). Secondary infections contribute to a more severe clinical course and longer intensive care unit (ICU) stays in patients with COVID-19. A man in his 60s was admitted to the ICU at a university hospital for severe COVID-19 pneumonia requiring mechanical ventilation. His respiratory condition worsened further due to persistent bacteremia caused by imipenem-non-susceptible Klebsiella aerogenes and he required VV-ECMO. Subsequently, he developed a catheter-related bloodstream infection (CRBSI) due to Candida albicans, ventilator-associated pneumonia (VAP) due to multidrug-resistant Pseudomonas aeruginosa (MDRP), and a perianal abscess due to carbapenem-resistant K. aerogenes despite infection control procedures that maximized contact precautions and the absence of MDRO contamination in the patient's room environment. He was decannulated from VV-ECMO after a total of 72 days of ECMO support, and was eventually weaned off ventilator support and discharged from the ICU on day 138. This case highlights the challenges of preventing, diagnosing, and treating multidrug-resistant organisms and healthcare-associated infections (HAIs) in the critical care management of severe COVID-19. In addition to the stringent implementation of infection prevention measures, a high index of suspicion and a careful evaluation of HAIs are required in such patients.

Keywords: COVID-19; carbapenem-resistant; case report; extracorporeal membrane oxygenation; healthcare-associated infections; intensive care; multi-resistant pathogens.
 
Back
Top Bottom